0001104659-20-033116.txt : 20200313
0001104659-20-033116.hdr.sgml : 20200313
20200313160806
ACCESSION NUMBER: 0001104659-20-033116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190603
FILED AS OF DATE: 20200313
DATE AS OF CHANGE: 20200313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSENWALD LINDSAY A MD
CENTRAL INDEX KEY: 0000941841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35366
FILM NUMBER: 20712711
MAIL ADDRESS:
STREET 1: 375 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10152
FORMER NAME:
FORMER CONFORMED NAME: ROSENWALD LINDSAY MD
DATE OF NAME CHANGE: 19950316
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fortress Biotech, Inc.
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205157386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC
DATE OF NAME CHANGE: 20080310
4
1
tm2011481-6_form4.xml
FORM 4
X0306
4
2019-06-03
0
0001429260
Fortress Biotech, Inc.
FBIO
0000941841
ROSENWALD LINDSAY A MD
C/O FORTRESS BIOTECH, INC.
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
1
1
0
PRESIDENT, CEO & CHAIRMAN
COMMON STOCK, PAR VALUE $0.001
2019-06-03
4
P
0
1467
1.10
A
8571189
D
COMMON STOCK, PAR VALUE $0.001
2019-12-01
4
P
0
1123
2.06
A
8572312
D
COMMON STOCK, PAR VALUE $0.001
2020-01-01
4
A
0
801536
0.00
A
9373848
D
Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period.
The Reporting Person was granted 801,536 restricted shares pursuant to the Issuer's Long Term Incentive Plan on January 1, 2020.
/s/ Samuel W. Berry / Attorney in Fact
2020-03-13